Novel paromamine derivatives exploring shallow-groove recognition of ribosomal-decoding-site RNA

ChemBioChem

Volumn 3, Issue 12, 2002, Pages 1223-1228

  Simonsen, Klaus B ^a   Ayida, Benjamin K ^a   Vourloumis, Dionisios ^a   Takahashi, Masayuki ^a   Winters, Geoffrey C ^a   Barluenga, Sofia ^a   Qamar, Seema ^a   Shandrick, Sarah ^a   Zhao, Qiang ^a   Hermann, Thomas ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Aminoglycosides; Antibiotics; Drug design; Medicinal chemistry; RNA recognition

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; PAROMAMINE DERIVATIVE; RIBOSOME RNA; UNCLASSIFIED DRUG;

ARTICLE; DRUG BINDING SITE; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; RIBOSOME; STRUCTURE ACTIVITY RELATION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BINDING SITES; CELL-FREE SYSTEM; DRUG DESIGN; PROTEIN BIOSYNTHESIS; RNA, BACTERIAL; RNA, RIBOSOMAL; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIA (MICROORGANISMS);

EID: 12244280014     PISSN: 14394227     EISSN: None     Source Type: Journal    
DOI: 10.1002/1439-7633(20021202)3:12<1223::AID-CBIC1223>3.0.CO;2-W     Document Type: Article

References (41)

1. (a) D. Moazed, H. F. Noller, Nature 1987, 327, 389-394;
2. (b) J. Woodcock, D. Moazed, M. Cannon, J. Davies, H. F. Noller, EMBO J. 1991, 10, 3099-3103;
3. (c) P. Purohit, S. Stern, Nature 1994, 370, 659-662.
4. (a) A. P. Carter, W. M. Clemons, D. E. Brodersen, R. J. Morgan-Warren, B. T. Wimberly, V. Ramakrishnan, Nature 2000, 407, 340-348;
5. (b) D. E. Brodersen, W. M. Clemons, A. P. Carter, R. J. Morgan-Warren, B. T. Wimberly, V. Ramakrishnan, Cell 2000, 103, 1143-1154;
6. (c) J. M. Ogle, D. E. Bordersen, W. M. Clemons, M. J. Tarry, A. P. Carter, V. Ramakrishnan, Science 2001, 292, 897-902.
7. G. D. Wright, A. M. Berghuis, S. Mobashery in Resolving the Antibiotic Paradox: Progress in Understanding Drug Resistance and Development of New Antibiotics (Eds.: B. P Rosen, S. Mobashery), Plenum, New York, 1998, pp. 27-69.
8. (a) V. Ramakrishnan, Cell 2002, 108, 557-572;
9. (b) R. Schroeder, C. Waidsich, H. Wank, EMBO J. 2000, 19, 1-9.
10. C.-H. Wong, M. Hendrix, E. S. Priestley, W. A. Greenberg, Chem. Biol. 1998, 5, 397-406.
11. (a) M. I. Recht, D. Fourmy, S. C. Blanchard, K. D. Dahlquist, J. D. Puglisi, J. Mol. Biol. 1996, 262, 421-436;
12. (b) D. Fourmy, M. I. Recht, S. C. Blanchard, J. D. Puglisi, Science 1996, 274, 1367-1371;
13. (c) D. Fourmy, S. Yoshizawa, J. D. Puglisi, J. Mol. Biol. 1998, 277, 333-345;
14. (d) D. Fourmy, M. I. Recht, J. D. Puglisi, J. Mol. Biol. 1998, 277, 347-362.
15. Q. Vicens, E. Westhof, Structure 2001, 9, 647-658.
16. C. Ma, N. A. Baker, S. Joseph, J. A. McCammon, J. Am. Chem. Soc. 2002, 124, 1438-1442.
17. P. Alper, M. Hendrix, P. Sears, C.-H. Wong, J. Am. Chem. Soc. 1998, 120, 1965-1978.
18. W. A. Greenberg, E. S. Priestley, P. S. Sears, P. B. Alper, C. Rosenbohm, M. Hendrix, S.-C. Hung, C.-H. Wong, J. Am. Chem. Soc. 1999, 121, 6527-6541.
19. S. Hanessian, M. Tremblay, A. Kornienko, N. Moitessier, Tetrahedron 2001, 57, 3255-3265.
20. J. Haddad, L. P. Kotra, B. Llano-Sotelo, C. Kim, E. F. Azucena, M. Liu, S. B. Vakulenko, C. S. Chow, S. Mobashery, J. Am. Chem. Soc. 2002, 124, 3229-3237.
21. (a) T. Hermann, Angew. Chem. 2000, 112, 1962-1979; Angew. Chem. Int. Ed. 2000, 39, 1890-1904;
22. (a) T. Hermann, Angew. Chem. 2000, 112, 1962-1979; Angew. Chem. Int. Ed. 2000, 39, 1890-1904;
23. (b) T. Hermann, E. Westhof, Comb. Chem. High Throughput Screening 2000, 3, 219-234;
24. (c) J. Gallego, G. Varani, Acc. Chem. Res. 2001, 34, 836-843.
25. L. P. Kotra, J. Haddad, S. Mobashery, Antimicrob. Agents Chemother. 2000, 44, 3249-3256.
26. (a) Y. Tor, T. Hermann, E. Westhof, Chem. Biol. 1998, 5, R277-R283;
27. (b) K. Michael, Y. Tor, Chem. Eur. J. 1998, 4, 2091-2098;
28. (c) T. Hermann, E. Westhof, Biopolymers 1999, 48, 155-165;
29. (d) S. J. Suchek, Y.-K. Shue, Curr. Opin. Drug Discovery Dev. 2001, 4, 462-470.
30. Molecular modeling was performed by using published atom coordinates of the 30S ribosomal-subunit-aminoglycoside complexes[2] and high-resolution crystal structures of a synthetic 35-nucleotide RNA construct, which contained the bacterial decoding-site internal loop (Q. Zhao, T. Hermann, unpublished results). The conformational space available to the 6′ hydroxy group of paromamine docked to the decoding-site RNA was explored by using the Insight/Discover (Accelrys) program and the AMBER force field following established protocols: T. Hermann, E. Westhof, J. Med Chem. 1999, 42, 1250-1261.
31. T. H. Haskell, J. C. French, Q. R. Bartz, J. Am. Chem. Soc. 1959, 81, 3480-3481.
32. P. B. Alper, S.-C. Hung, C.-H. Wong, Tetrahedron Lett. 1996, 37, 6029-6032.
33. K. C. Nicolaou, G. Vassilikogiannakis, R. Kranich, P. S. Baran, Y.-L. Zhong, S. Natarajan, Org. Lett. 2000, 2, 1895-1898.
34. S. Cacchi, D. Misiti, F. La Torre, Synthesis 1980, 243-244.
35. J. Izdedski, D. Pawlak, Synthesis 1989, 423-425.
36. For compounds with 1,2-, 1,3-, and 1,6-cyclic imidate on the carbohydrate scaffold, see, for example: a) A. Vasella, C. Witzig, Helv. Chim. Acta. 1995, 78, 1971-1982;
37. (b) R. G. Dushin, S. J. Danishefsky, J. Am. Chem. Soc. 1992, 114, 3471-3475;
38. (c) S. Allemann, J.-L. Reymand, P. Vogel, Helv. Chim. Acta. 1990, 73, 674-689.
39. S. Shandrick, S. Qamar, T. Hermann, 2002, submitted.
40. S. Hanessian, M. Tremblay, A. Kornienko, N. Moitessier, Tetrahedron 2001, 57, 3255-3265.
41. J.-H. Zhang, T. D. Y. Chung, K. R. Oldenburg, J. Biomol. Screening 1999, 2, 67-73.